Institutional Ownership Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX). We have compiled data on the 181 institutions that hold shares in the stock, with a total of 38.5 Million shares, which have been reported (via 13F filing form) to have a value of $492 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bvf Inc
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
19,751,284
shares
|
$252 Million
7.66% of portfolio
|
Q4 2024
Reduced 9.19%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
2,000,000
shares
|
$25.5 Million
0.2% of portfolio
|
Q3 2025
Reduced 51.81%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,994,173
shares
|
$25.5 Million
2.28% of portfolio
|
Q3 2025
Reduced 76.52%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,699,235
shares
|
$21.7 Million
0.02% of portfolio
|
Q3 2025
Added 301.55%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,500,000
shares
|
$19.2 Million
0.02% of portfolio
|
Q3 2025
New holding
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
965,405
shares
|
$12.3 Million
0.05% of portfolio
|
Q3 2025
New holding
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
894,005
shares
|
$11.4 Million
0.05% of portfolio
|
Q2 2023
New holding
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
822,957
shares
|
$10.5 Million
0.0% of portfolio
|
Q3 2025
Reduced 68.51%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
635,699
shares
|
$8.12 Million
0.0% of portfolio
|
Q3 2025
Reduced 19.69%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
595,581
shares
|
$7.61 Million
0.01% of portfolio
|
Q4 2024
Added 2.55%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
454,268
shares
|
$5.8 Million
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2025 Q3 2025 |
435,839
shares
|
$5.57 Million
0.49% of portfolio
|
Q3 2025
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
392,024
shares
|
$5.01 Million
0.0% of portfolio
|
Q2 2024
Reduced 3.98%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
362,871
shares
|
$4.63 Million
0.0% of portfolio
|
Q3 2025
Reduced 71.55%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 13, 2025 Q3 2025 |
321,109
shares
|
$4.1 Million
0.0% of portfolio
|
Q3 2025
Reduced 39.32%
|
|
|
Verition Fund Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
272,768
shares
|
$3.48 Million
0.01% of portfolio
|
Q3 2025
Added 1059.38%
|
|
|
First Turn Management, LLC
Del Mar, CA |
Nov 14, 2025 Q3 2025 |
262,643
shares
|
$3.35 Million
0.28% of portfolio
|
Q3 2025
New holding
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
258,779
shares
|
$3.3 Million
0.03% of portfolio
|
Q3 2025
New holding
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
256,655
shares
|
$3.28 Million
0.0% of portfolio
|
Q3 2025
Added 493.57%
|
|
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
Nov 13, 2025 Q3 2025 |
207,000
shares
|
$2.64 Million
0.17% of portfolio
|
Q3 2025
Added 360.0%
|
|
|
Schroder Investment Management Group
London, X0 |
Nov 12, 2025 Q3 2025 |
195,490
shares
|
$2.5 Million
0.0% of portfolio
|
Q3 2025
Added 908.2%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
194,741
shares
|
$2.49 Million
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Exome Asset Management LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
178,084
shares
|
$2.27 Million
0.77% of portfolio
|
Q3 2025
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
174,161
shares
|
$2.22 Million
0.0% of portfolio
|
Q3 2025
Added 20608.8%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2025 Q3 2025 |
151,495
shares
|
$1.93 Million
0.1% of portfolio
|
Q3 2025
Added 341.5%
|
|